Lung Cancer Risk Calculator

The Lung Cancer Risk Calculator estimates an individual's risk of developing lung cancer based on key demographic, smoking, and clinical factors. Lung cancer risk prediction is critical for identifying individuals who would benefit from low-dose computed tomography (LDCT) screening, which has been proven to reduce lung cancer mortality by 20-24% in high-risk populations.

Lung cancer remains the leading cause of cancer death worldwide, responsible for approximately 1.8 million deaths annually. In the United States, over 230,000 new cases are diagnosed each year, with roughly 130,000 deaths. The 5-year survival rate for lung cancer is approximately 23% overall, but when detected at an early stage through screening, survival exceeds 60%. This stark difference underscores the critical importance of risk-based screening.

This calculator incorporates six validated risk factors: age, cumulative smoking exposure (pack-years), time since quitting, body mass index, family history of lung cancer, and presence of COPD or emphysema. These factors were identified in large epidemiological studies and lung cancer screening trials as independent predictors of lung cancer development.

Smoking history is the dominant risk factor, accounting for approximately 85% of all lung cancer cases. Risk is quantified in pack-years (packs per day multiplied by years of smoking). A 30 pack-year history (e.g., 1 pack/day for 30 years) roughly doubles risk compared to a 15 pack-year history. Quitting smoking reduces risk over time, with significant benefit beginning after 5 years, though former smokers remain at elevated risk for decades.

The US Preventive Services Task Force (USPSTF) 2021 guidelines recommend annual LDCT screening for adults aged 50-80 who have a 20+ pack-year smoking history and currently smoke or have quit within the past 15 years. This expanded criteria (previously age 55-80 with 30+ pack-years) significantly increased the eligible screening population and improved inclusion of women and racial/ethnic minorities.

COPD and emphysema are independent risk factors for lung cancer beyond their association with smoking. Chronic inflammation, impaired mucociliary clearance, and shared genetic susceptibility contribute to this elevated risk. Similarly, a family history of lung cancer in a first-degree relative increases risk by approximately 1.5-2 fold, suggesting genetic predisposition factors.